Media Release
PHARMAC, AstraZeneca agree to continued drug supply
People will be able to continue taking all dosage strengths of the calcium channel blocker drug felodipine.
PHARMAC Chief Executive Wayne McNee says an agreement reached between the Government drug funding agency and
pharmaceutical company AstraZeneca will enable people to have uninterrupted access to the drug.
Wayne McNee says he is pleased that discussions with AstraZeneca have resulted in an agreement being reached.
[ends]